Diosbulbin D
CAS: 66756-57-8
Ref. 3D-RCA75657
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- (2S,4aS,6aS,7R,10R,11aR,11bS)-2-(3-Furanyl)octahydro-11b-methyl-7,10-methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, (2S,4aS,6aS,7R,10R,11aR,11bS)-
- 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, [2S-(2α,4aβ,6aα,7α,10α,11aβ,11bα)]-
- NSC 310637
- Neodiosbulbin
Diosbulbin D is a tetrahydrocannabinol (THC) derivative that has been identified as a matrix effect agent. It is a potent, selective and orally active inhibitor of the enzyme fatty acid amide hydrolase (FAAH). Diosbulbin D selectively blocks the hydrolysis of anandamide and other endocannabinoids, which are lipid-signaling molecules produced by the body. This prevents their degradation, leading to increased levels of these compounds in the body. The effects of this drug have been analyzed using LC-MS/MS method on bladder cancer cells, pancreatic cancer cells and skin cancer cells. The results suggest that it may be an effective treatment for cancers characterized by elevated FAAH levels.
Propriedades químicas
Consulta técnica sobre: 3D-RCA75657 Diosbulbin D
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
